I currently have approx 19k shares. In the past 5 days, the stock price has jumped up +34.36%. I think that trend will continue the closer we get to the results next month.
Recently, Madrigal Pharmaceuticals (MDGL) got positive news for their phase 3 Nash trials on Friday night. Their stock more than tripled on the news from $63.60 to $207.80 on Monday. I think that Oramed has the potential to do just as well or better with positive results.
Oramed is the first company to get an oral insulin pill to phase 3 and we are literally just a few weeks away from knowing if this stock will shoot up like a rocket or crater on the launchpad.
The insulin market is massive. If successful, Oramed will make their stockholders rich. What's even more impressive is that if Oramed is successful with their endeavors, they could have pieces of FOUR MASSIVE ADDRESSABLE MARKETS:
INSULIN = 59 Billion market by 2024
NASH = 54 Billion market by 2024
COVID = 25 Billion market by 2024
GLP-1 = 18.2 Billion market by 2024
59 + 54 + 25 + 18.2 = 156.2 billion in addressable markets by 2024
I was curious what your thoughts are on Oramed's chances next month.
Leave a Reply